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Letter to the Editor
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Meeting Announcements
THE FIRST EUROPEAN CONGRESS ON THERMOGRAPHY
AMSTERDAM, THE NETHERLANDS
17 JUNE-20 JUTNE 1974
Organized by the European Thermographic
Association with the collaboration of the
American Thermographic Society.
President: H. Aarts.
Secretary General: M. Gautherie.
Scientific; Programme: The Scientific Pro-
gramme will consist of Lectures by invited
speakers, specialized papers, audiovisual dis-
plays, and scientific and technical exhibits.
All the lectures and demonstrations will
take place at the International Congrescen-
trum RAI, Europaplein 12, Amsterdam.
Registration Fees: Full participants, 275 Fl.
Associated participants, 150 Fl. Increased
fees will be applied at late registration (after
February 29, 1974). Reduced fees for mem-
bers of the European Thermographic Associ-
ation (who have paid their annual subscrip-
tion), 225 Fl. A registration form will be
sent with the Intermediate Programme.
Official Languages: Papers will be delivered
in English, French or German and there will
be simultaneous translation into English,
French and German.
Secretariat: 1st European Congress on
Thermography, Organisatie Bureau Amster-
dam N.V., P.O. Box 7205, Amsterdam, The
Netherlands, Tel. 020-44 08 07 (Telex 13499
Raico).